Genomatica Expands Bioengineering Solutions Business SAN

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Genomatica Expands Bioengineering Solutions Business

SAN DIEGO, April 12, 2016 (GLOBE NEWSWIRE) -- Genomatica announced they are expanding their Bioengineering Solutions business across the chemical, health (e.g. active pharmaceutical ingredients, natural products), wellness (e.g. nutraceuticals, personal care) and food and beverage industries. Genomatica’s offerings will now enable a broader range of customers to complement their in-house expertise and more rapidly and reliably deploy commercial biobased processes.

The expansion of Genomatica’s Bioengineering Solutions group follows more than ten projects to their credit. These projects span the product development lifecycle, are spread out internationally, involve both bacteria and yeast, for both large and small companies. In addition, the company added two new customers in the last month focused on yeast fermentation processes for producing a food ingredient and a nutraceutical. The group’s solution offerings include:

  • Evaluation studies : assess new bioprocess ideas using techno-economic analysis and computational biology tools, vetting a customer’s business case before they commit significant R&D dollars; next steps may include a proof-of-concept demonstration;
  • Strain diagnostics : provides a ‘view inside the cell’ to gain deep understanding of metabolism using systems modeling, omics, quantitative small-scale (QSS) technology and precision fermentation; provide recommendations to rapidly overcome metabolic pathway bottlenecks;
  • Pathway enzyme engineering: develop enzymes that work in the context of a whole metabolic pathway for improved in vivo performance; including high throughput screening for activity and specificity on non-natural substrates, using ‘smart’ assays/libraries;
  • Scale-up preparedness : enable reliable fermentation scale-up and/or contract manufacturing; improve strain and process robustness for successful technology transfer;
  • Integrated strain and process development : apply Genomatica’s complete set of bioengineering capabilities and technology platform to help enable new business opportunities or improve existing fermentation processes.

“Genomatica has proven its ability to industrialize multiple processes and continues to deliver bioengineering innovations,” said Christophe Schilling, CEO of Genomatica. “Savvy customers beyond licensees of our existing product lines sought us out and benefited. A common thread has been to apply our diagnostic tools and systems approach to break through tough spots in a development process and de-bottleneck projects. Now, we’re pleased to leverage our platform and bioengineering approach to add value to more firms, with expanded market applications that include health, wellness, and food and beverage.”

Proven, integrated platform and bioengineering approach provide unique advantages Genomatica has developed a unique, proprietary platform that intertwines advanced computation (biological modeling, computer aided design, optimization, complex systems analysis), metabolic engineering (genetic manipulation, synthetic biology), and a bioengineering approach and tools (see ‘ Harnessing Biotechnology: A Practical Guide ,’ Chemical Engineering , April 2016) to support optimal design and development of complete, scalable bioprocesses. Through this platform, Genomatica offers the following distinctive, core capabilities to customers:

a)‘commercial-scale-first’ thinking: we envision what’s needed for real commercial deployments, and design strains and processes with the end in mind; b) systems design’ mindset: our integrated platform enables a holistic approach to co-optimization of complex problems, where the right issues are addressed in the right sequence; c) ‘industrial-strength’ engineering of microorganisms: proven abilities to develop commercially-deployable strains; d) expertise in scale-up and, equally important, scale-down: using both modeling and precision experimentation, we can reliably translate lab performance to commercial scale (e.g. >600 m 3 fermentors), effectively reducing the time and cost of scale-up; e) technology transfer skills: Genomatica has deployed and/or transferred various parts of its process technologies to a dozen sites around the world, across varying equipment, countries, languages, and cultures – a skill honed by working with licensees of its processes for high-volume intermediate chemicals; f) track record: consistent history of delivering on challenging targets, on-time and on-budget.

“Genomatica’s Bioengineering Solutions business enables our customers to deliver better products faster and more reliably than by doing it all themselves,” said Schilling. “The industry has learned that it’s the ‘whole process’ that counts, and Genomatica can help at specific points while always focusing on the end result. We are bringing our track record of commercial success, and translating it into a positive impact for products and customers outside of our core product lines – all by collaborating with Genomatica.”

Potential customers should contact Solutions@genomatica.com for more information.

About Genomatica Genomatica is a widely-recognized leader in bioengineering. It develops biobased process technologies and helps customers develop solutions that enable a ‘better way’ to produce chemicals, from a range of alternative feedstocks, and with better economics, sustainability and performance. Partners include ENI Versalis, Braskem, BASF, Novamont and Cargill. Genomatica is distinctive in its ‘total-solutions’ approach, supported by its bioengineering platform, which intimately intertwines and co-optimizes microorganism design, bioprocess design and economics.

Genomatica has earned widespread acclaim for its scientific, engineering and commercialization achievements. Awards include the Kirkpatrick Award , for ‘the most noteworthy chemical engineering technology commercialized in the world,’ and the 2015 World Economic Forum Technology Pioneer award. To learn more, see www.genomatica.com .

For more information: Rob Adler, radler@pancomm.com , 415.984.1970 x0104

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 0

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
CSMI Boosts CT's Cybersecurity for Defense Sector

Updated Category News Views 132

Paving the Way for Cybersecurity Excellence Out in chilly Connecticut, CSMI made a mark. The State's Office of Manufacturing picked them to join the advisory council for the Defense CyberSecure Program (CT-DCP). It ain’t just a pat on the back; it's a big deal for the region's defense and aerospace manufacturing gang. Connecticut's got its eyes set on beefing up its...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 207

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 244

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 0

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 53

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
Wall Street Gains Hold Amid Volatility Drop

Updated Category News Views 66

A Week of Gains and Regulatory Moves Right out of the gate, it’s been a decent stretch for Wall Street. Weekly gains kept the party going, even as traders navigated the usual hurdles. Stocks finished the week with a solid performance—all the heavy hitters like Dow, S&P 500, Nasdaq, and Russell 2000 ended on a high note, waltzing uphill past where many imagined...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 84

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 88

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Scribd’s First Safety Report Shows Enforcement at Scale

Updated Category News Views 0

Forty-seven million enforcement actions is not a decorative statistic Scribd finally put some hard numbers on a problem most document platforms prefer to discuss in foggy corporate language. Its first transparency report, covering January through June 2026, says the company took more than 47 million moderation actions across Scribd and Slideshare. That is a hulking...

Continue Reading

Top 5 Most Recently Viewed Articles

Uwill Achieves Remarkable Growth as Third Fastest-Growing Firm

Updated Category News Views 278

Uwill Makes Its Mark in the Mental Health Arena In a remarkable achievement, Uwill has been recognized as one of the top mental health and wellness solutions for students, claiming the third position on the highly acclaimed Inc. Regionals: Northeast list. This ranking highlights the company's commitment to innovation and growth, as it operates in a vital field that...

Continue Reading
South University Celebrates Milestone With Ceremony and Capsule

Updated Category News Views 110

South University Marks 125 Years of Educational Excellence South University is proud to announce a significant celebration to commemorate its 125th anniversary. The event, which will include a time capsule ceremony along with a reception, is set to take place at the university's historic Savannah campus. This occasion not only honors the past but also emphasizes the...

Continue Reading
Insights on Ultra Clean Holdings' Upcoming Class Action Lawsuit

Updated Category News Views 160

Understanding the Class Action Lawsuit Against Ultra Clean Holdings The Gross Law Firm is here to inform investors of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) about an important class action lawsuit that is currently pending. This notice is directed towards shareholders who acquired shares of UCTT during the specified class period. The opportunity to participate in this...

Continue Reading
APA.LIVE and YES, And… Forge a Fresh Event Path

Updated Category News Views 30

Innovation Takes Center Stage in Live Productions Well, this one's a bit different, folks. When it comes to corporate meetings that are supposed to shake off the dust of dread and monotony, APA.LIVE is punching above its weight class. These guys are taking a swing at traditional snooze-inducing conferences by partnering with YES, And… Creative Services. With APA.LIVE...

Continue Reading
NVIDIA's Blackwell Demand Skyrockets Amid Strategic Partnership

Updated Category News Views 207

NVIDIA Corporation (NASDAQ: NVDA) was making waves back in 2024, boasting a year-to-date surge of 136% as traders flocked to the innovative tech company. Shares popped by 1.6% following CEO Jensen Huang’s bullish remarks on CNBC's Closing Bell Overtime regarding their latest product, Blackwell. You could practically hear the buzz on the trading floor as desks reacted to...

Continue Reading